"Atovaquone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols.
| Descriptor ID |
D053626
|
| MeSH Number(s) |
D02.806.550.312 D04.615.638.721.186
|
| Concept/Terms |
Atovaquone- Atovaquone
- 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
- 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
566C80- 566C80
- hydroxynaphthoquinone 566C80
- 566C80 hydroxynaphthoquinone
- hydroxynaphthoquinone, 566C80
|
Below are MeSH descriptors whose meaning is more general than "Atovaquone".
Below are MeSH descriptors whose meaning is more specific than "Atovaquone".
This graph shows the total number of publications written about "Atovaquone" by people in this website by year, and whether "Atovaquone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Atovaquone" by people in Profiles.
-
Mascarenhas TR, Silibovsky RS, Singh P, Belden KA. Tick-borne illness after transplantation: Case and review. Transpl Infect Dis. 2018 Apr; 20(2):e12830.
-
Boggild AK, Krudsood S, Patel SN, Serghides L, Tangpukdee N, Katz K, Wilairatana P, Liles WC, Looareesuwan S, Kain KC. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2009 Sep 15; 49(6):841-9.
-
van de Poll ME, Relling MV, Schuetz EG, Harrison PL, Hughes W, Flynn PM. The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2001 Jun; 47(6):467-72.
-
Hughes WT, Kennedy W, Shenep JL, Flynn PM, Hetherington SV, Fullen G, Lancaster DJ, Stein DS, Palte S, Rosenbaum D, et al. Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. J Infect Dis. 1991 Apr; 163(4):843-8.